key: cord-1007682-fzbs46fk authors: Kjellberg, Anders; De Maio, Antonio; Lindholm, Peter title: Can Hyperbaric Oxygen safely serve as an anti-inflammatory treatment for COVID-19? date: 2020-08-30 journal: Med Hypotheses DOI: 10.1016/j.mehy.2020.110224 sha: 6640a0474ad85a73399a78a8adfce33895d9a830 doc_id: 1007682 cord_uid: fzbs46fk INTRODUCTION: SARS-CoV-2 affects part of the innate immune response and activates an inflammatory cascade stimulating the release of cytokines and chemokines, particularly within the lung. Indeed, the inflammatory response during COVID-19 is likely the cause for the development of acute respiratory distress syndrome (ARDS). Patients with mild symptoms also show significant changes on pulmonary CT-scan suggestive of severe inflammatory involvement. HYPOTHESIS: The overall hypothesis is that HBO(2) is safe and reduces the inflammatory response in COVID-19 pneumonitis by attenuation of the innate immune system, increase hypoxia tolerance and thereby prevent organ failure and reduce mortality. EVALUATION OF THE HYPOTHESIS: HBO(2) is used in clinical practice to treat inflammatory conditions but has not been scientifically evaluated for COVID-19. Experimental and empirical data suggests that HBO(2) may reduce inflammatory response in COVID-19. However, there are concerns regarding pulmonary safety in patients with pre-existing viral pneumonitis. EMPIRICAL DATA: Anecdotes from “compassionate use” and two published case reports show promising results. CONSEQUENCES OF THE HYPOTHESIS AND DISCUSSION: Small prospective clinical trials are on the way and we are conducting a randomized clinical trial. SARS-CoV-2 affects part of the innate immune response and activates an inflammatory cascade stimulating the release of cytokines and chemokines, particularly within the lung (1, 2) . The export of these factors attracts neutrophils and monocytes to the site of infection, infiltrating the organ. Unfortunately, neutrophils are particularly inefficient in clearing viral infections, and their presence may be more detrimental than beneficial due to the release of a battery of caustic agents directed at killing the pathogen, but they could also damage the surrounding tissue (3) . The destruction of host cells may release subcellular elements that could trigger secondary inflammatory reactions. Thus, SARS-CoV-2 infection activates a robust inflammatory response that if it is not controlled, could result in a "cytokine storm" with detrimental systemic consequences (4) . Indeed, the inflammatory response during COVID-19 is likely the cause for the development of acute respiratory distress syndrome (ARDS) in patients, which is a condition of very low arterial oxygen concentration or hypoxia and bilateral pulmonary opacities (5) . A post-mortem biopsy of pulmonary tissue from a 72-yearold man that died 3 weeks after the onset of symptoms was described as "diffuse alveolar damage, with reactive type II pneumocyte hyperplasia, intra-alveolar fibrinous exudates were present and loose interstitial fibrosis and chronic inflammatory infiltrates" (6) . Even patients that have mild symptoms and survived COVID-19 displayed significant changes on pulmonary CT-scan, with diffuse ground-glass opacities, crazy-paving patterns, and consolidation, suggesting a severe inflammatory involvement (7) . So far, specific treatments have been difficult to advance among more than 160 clinical trials registered since March 2020 (8) . Recently, a double-blind clinical trial using the drug Remdesivir, which was originally developed for the treatment of Ebola virus, showed an improvement in the resolution of severely ill COVID-19 patients, opening a ray of hope(9). However, a cure for the disease is still yet to come. Several groups are also rapidly working on the development of a possible vaccine, but this endeavour may be months or years away from reality. Hyperbaric Oxygen (HBO 2 ) consists of exposure to 100% oxygen under increased atmospheric pressure. This procedure allows the delivery of oxygen at high partial pressure reaching tissues rapidly at elevated concentrations. HBO 2 has been used for almost a century, initially for decompression sickness (DCS), but it was soon noted that it had several anti-inflammatory effects (10, 11) . HBO 2 is shown to be effective in treatment of radiation 4 (11) injury (12) (13) (14) and wound healing (15) . In all cases, HBO 2 has been used with great safety, and with very few adverse effects. The overall hypothesis is that HBO 2 is safe and reduces the inflammatory response in COVID-19 pneumonitis by attenuation of the innate immune system, increase hypoxia tolerance and thereby prevent organ failure and reduce mortality. We propose that HBO 2 could be an early intervention for COVID-19 patients, utilized at the first signs of decline in oxygen blood saturation levels as well as for critically ill patients, A few treatments with HBO 2 has the potential to reduce inflammation, restore normal defence mechanisms and thereby reduce the detrimental effects of oxygen requirement in COVID-19 pneumonitis. Recent evidence from animal studies suggest that HBO 2 ameliorate inflammation in Decompression Sickness (DCS) induced Acute lung injury (ALI) through polarization of macrophages from inflammatory macrophage subtype (M1) to resolving or anti-inflammatory sub type (M2) (16, 17) . Hyperbaric oxygen has been shown to polarize macrophages from M1 to M2 associated with IL-10 and thereby reduce inflammation (18, 19) and 30 min HBO 2 ex vivo inhibit monocyte IL-1β and TNF-α (20) . Interestingly, the switch from M1 to M2 was described in a human study of ALI/ARDS (21) . HBO 2 allows the delivery of oxygen at high partial pressure reaching tissues rapidly at elevated concentrations, which could reverse the hypoxic condition and preserve cellular metabolism (22) . Indeed, HBO 2 has been shown to preserve mitochondrial activity (23) . Moreover, HBO 2 improved kidney function after infection (24) , protected organs from ischemia/reperfusion injury (25, 26) , reduced UV skin damage (27) , and avoided kidney damage in diabetic patients (28) . Studies using an experimental animal model of sepsis that is characterized by an overwhelming inflammatory response showed a significant improvement in mortality after a single HBO 2 treatment (2.4 Atmospheres absolute (ATA), 60 min) very early after the initial insult. The improved outcome was correlated to a reduction in inflammation (29) . This observation echoes prior investigations using multiple HBO 2 treatments to improve the outcome of rodent sepsis (18) . Additionally, HBO 2 was reported to reduce bacterial infections (24, 30, 31) and LPS toxicity (32, 33) . HBO 2 has been noticed to display several anti-inflammatory effects (10, 11, 29) , perhaps due to modulation of oxidative stress (34) , or a direct effect on the innate immune system (35) . HBO 2 significantly reduces 5 (11) inflammatory cytokines through several transcriptional factors, including Hypoxia Inducible Factor 1 (HIF-1) (36, 37) and nuclear factor kappa-light-chain-enhancer of activated B cells (NFkB) (18) (19) (20) 38) . Other studies have shown that HBO 2 activates additional transcriptional factors, including Nuclear factor erythroid 2-related factor 2 (Nrf-2) and Heat shock factor 1 (HSF1), that are involved in the expression of several defense proteins (39) . HBO 2 has been evaluated in clinical trials as safe and may be effective for a number of acute inflammatory conditions such as pancreatitis (40) , ulcerative colitis flares (41) . There is a wide range of pressures and times used for HBO 2 treatments, with preferences for the use of 1.6 to 2.5 ATA. Anti-inflammatory effects have been observed in conditions of 2 ATA for 60 min in the lung of healthy individuals. Thus, we hypothesize that the "dose" can be estimated as "area under the curve". If the "area under the curve" is representing the dose, 2 ATA for 60 minutes would be equivalent to 2.4 ATA for 50 minutes. The chosen protocol for the study aimed to enable inclusion of centres with practices (and hardware) for a range of pressures. Oxygen is known to have several toxic effects when used for a prolonged time. Toxicity is dose dependent and measured in Units of pulmonary Toxic Dose (UPTD) also called Oxygen Tolerance Unit (OTU); tables for maximal dose is regulated for divers. One UPTD is equivalent of breathing 100% oxygen for 1 minute at 1 Bar. Surprisingly UPTD is not recorded in medical practice despite oxygen for medical use is a regulated drug. It is well accepted that oxygen induce toxic changes in the lungs and airways but chronic oxygen toxicity in other organs including immunological effects are less explored (42) . Reversible and non-reversible oxygen toxicity in the eyes are well known side effects of HBO 2 that normally occur after 20-40 HBO 2 treatments (43) . It has been suggested that Fi0 2 below 0.5 (50% O 2 ) is safe but it is known that many factors including viral infections, mechanical ventilation and other drugs can synergistically add to oxygen toxicity (42) . Acute severe toxicity is normally only seen in hyperbaric settings > 200kPa and include CNS toxicity presenting as blurred vision and in worst case self-limiting seizures (44) , occurring in < 1/10.000 treatments. Paradoxically intermittent HBO 2 has also been shown to protect lungs against oxygen toxicity by upregulation of anti-oxidative factors (45, 46) . Even though concerns of pulmonary toxicity are theoretical for the proposed treatment duration (47) , the extent of COVID-19 pathology is unknown and potential toxic effect of oxygen should be monitored in a randomized clinical trial. The potential for the use of HBO 2 in the case of COVID-19 was demonstrated by two case reports from Wuhan, China, which showed an improvement in the condition of severely ill patients by increasing blood oxygen saturation levels and reducing lung inflammation (48) . In 6 (11) a recently published case series Louisiana, USA, 5 patients with "impeding intubation" was treated with hyperbaric oxygen, patients symptoms was immediately relieved and they all recovered after 1-6 treatments without intubation and mechanical ventilation (49) . In addition, HBO 2 has been reported to be safe during the use of mechanical ventilation (50) . Currently, half a dozen new clinical trials are underway in several countries, including casecontrolled trials that may generate a rapid information that could be of utility in dealing with the current pandemic. HBO 2 is used on "compassionate grounds" just as other antiinflammatory drugs such as Chloroquine, cortisone and L-6 inhibitors but randomized trials are absent and/or have been discouraging. Well designed and sufficiently powered randomized trails are needed to confirm safety and efficacy of HBO 2 for both current and future viral respiratory diseases. Hence, we have designed and planned a clinical trial in accordance with ICH-GCP and "the Helsinki Declaration": "Safety and Efficacy of Hyperbaric Oxygen for Improvement of Acute Respiratory Distress Syndrome in Adult Patients With COVID-19; a Randomized, Controlled, Open Label, Multicentre Clinical Trial" (NCT04327505). We have ethical-and competent authority approval, initiated our first center and have included our first few subjects. Coronaviruses post-SARS: update on replication and pathogenesis Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology Neutrophil in viral infections, friend or foe? The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak -an update on the status Understanding a Heterogeneous Syndrome Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia COVID-19: a novel coronavirus and a novel challenge for critical care Hopes rise for coronavirus drug remdesivir Hyperbaric oxygen: its uses, mechanisms of action and outcomes Hyperbaric oxygen: its mechanisms and efficacy Hyperbaric oxygen therapy for late radiation tissue injury Radiation-induced cystitis treated with hyperbaric oxygen therapy (RICH-ART): a randomised, controlled Hyperbaric Oxygen Therapy and Radiation-Induced Injuries Hyperbaric Oxygen Indications: Diabetic Foot Ulcers and Intractable Management Polarization of macrophages in the blood after decompression in mice Hyperbaric oxygen treatment reduced the lung injury of type II decompression sickness Hyperbaric oxygen protects from sepsis mortality via an interleukin-10-dependent mechanism Hyperbaric oxygen reduces inflammation, oxygenates injured muscle, and regenerates skeletal muscle via macrophage and satellite cell activation Hyperbaric oxygen inhibits stimulus-induced proinflammatory cytokine synthesis by human blood-derived monocyte-macrophages Comparative analysis of the alveolar macrophage proteome in ALI/ARDS patients between the exudative phase and recovery phase COVID-19, Acute Respiratory Distress Syndrome (ARDS) and Hyperbaric Oxygen Therapy (HBOT): What is the link? The effect of hyperbaric oxygen on mitochondrial and glycolytic energy metabolism: the caloristasis concept The effect of hyperbaric oxygen treatment on the renal functions in septic rats: relation to oxidative damage Endothelial-neutrophil interactions during ischemia and reperfusion injury: basic mechanisms of hyperbaric oxygen Preconditioned hyperbaric oxygenation protects the liver against ischemia-reperfusion injury in rats Hyperbaric oxygen preconditioning protects skin from UV-A damage Might hyperbaric oxygen therapy (HBOT) reduce renal injury in diabetic people with diabetes mellitus? From preclinical models to human metabolomics Early hyperbaric oxygen therapy improves survival in a model of severe sepsis Intermittent hyperbaric oxygen therapy for reduction of mortality in experimental polymicrobial sepsis Inhibition of Pseudomonas aeruginosa by hyperbaric oxygen: interaction with mouse peritoneal exudate cells Hyperbaric oxygen protects against lipopolysaccharide-stimulated oxidative stress and mortality in rats Beneficial effect of hyperbaric oxygen pretreatment on lipopolysaccharide-induced shock in rats Oxidative stress is fundamental to hyperbaric oxygen therapy Reactive oxygen species regulate innate but not adaptive inflammation in ZAP70-mutated SKG arthritic mice Anti-Inflammatory Effects of Hyperbaric Oxygenation during DSS-Induced Colitis in BALB/c Mice Include Changes in Gene Expression of HIF-1alpha Hyperbaric oxygen reduces acetaminophen toxicity and increases HIF-1alpha expression Modification of HIF-1alpha, NF-akappaB, IGFBP-3, VEGF and adiponectin in diabetic foot ulcers treated with hyperbaric oxygen Hyperbaric oxygen induces a cytoprotective and angiogenic response in human microvascular endothelial cells Hyperbaric oxygen therapy is well tolerated and effective for ulcerative colitis patients hospitalized for moderate-severe flares: a phase 2A pilot multi-center, randomized, double-blind, sham-controlled trial Should Oxygen Therapy Be Tightly Regulated to Minimize Hyperoxia in Critically Ill Patients? Hyperbaric Oxygen Therapy: Side Effects Defined and Quantified Oxygen Toxicity and Special Operations Forces Diving: Hidden and Dangerous Mechanisms of protection against pulmonary hyperbaric O(2) toxicity by intermittent air breaks Intermittent hyperbaric oxygen exposure mobilizing peroxiredoxin 6 to prevent oxygen toxicity Hyperbaric oxygen as a treatment for COVID-19 infection? Hyperbaric oxygen therapy may be effective to improve hypoxemia in patients with severe COVID-2019 pneumonia: two case reports Hyperbaric oxygen therapy in preventing mechanical ventilation in COVID-19 patients: a retrospective case series Safety of hyperbaric oxygen therapy in mechanically ventilated patients This article has no funding. The randomized controlled trial has been planned and initiated with funding from the Swedish Research Council, made available by redirecting funds from Kenny Rodriguez-Wallberg at the department of Pathology-Oncology, Karolinska Institutet The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.